Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.390EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.390EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.390ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.390ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.390EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.390EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.390ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.390ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.539ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.35ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.35ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.35EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.54EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.54ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.54ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.54EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.54EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.164EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.164EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.164ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.164ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.164EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.164EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.164ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.164ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used